Childrens Tussnex

Description

Childrens Tussnex Multi-symptom Cold and Fever is a combination medication formulated to address multiple symptoms associated with colds and fevers in pediatric patients. The active ingredients include acetaminophen, which serves as a pain reliever and fever reducer; dextromethorphan HBr, functioning as a cough suppressant; guaifenesin, an expectorant that thins and loosens mucus; and phenylephrine HCl, a nasal decongestant that relieves nasal and chest congestion. This formulation is alcohol-free and is designed to soothe cough, reduce fever, and alleviate respiratory discomfort.

Uses and Indications

This drug is indicated for the temporary relief of common cold and flu symptoms, including nasal congestion, stuffy nose, cough due to minor throat and bronchial irritation, and the intensity and impulse to cough, particularly to assist children in achieving sleep. It also alleviates minor aches and pains, sore throat, headache, and temporarily reduces fever. Additionally, this medication helps to loosen phlegm (mucus) and thin bronchial secretions, facilitating drainage of the bronchial tubes and making coughs more productive.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

This product is intended for use in children aged 6 years and older. The recommended dosage for children aged 6 to under 12 years is 10 mL, to be measured using the dosing cup provided. It is imperative that the dosing cup is not used with any other products to ensure accurate measurement.

Healthcare professionals should advise caregivers to shake the product well before each use. The dosing frequency may be repeated every 4 hours as needed while symptoms persist, but it is crucial not to exceed 5 doses within a 24-hour period. Additionally, the total duration of use should not exceed 5 days unless directed by a physician.

For children under 6 years of age, the use of this product is not recommended. Caregivers should be cautioned against exceeding the recommended dosage and should be made aware of the overdose warning associated with this product.

Contraindications

Use of this product is contraindicated in the following situations:

• Co-administration with any other drug containing acetaminophen, as this may increase the risk of liver damage.

• In children who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or within 2 weeks of discontinuing such medication, due to potential interactions that may lead to serious side effects.

• Exceeding the recommended dosage, as this poses a risk of overdose and subsequent liver damage.

Patients should discontinue use and consult a healthcare professional if they experience nervousness, dizziness, or sleeplessness; if pain, nasal congestion, or cough worsens or persists beyond 5 days; if fever worsens or lasts more than 3 days; if redness or swelling occurs; or if new symptoms develop. Additionally, if a cough recurs or is accompanied by a rash or persistent headache, medical advice should be sought, as these may indicate a serious condition. In the event of an overdose, immediate medical attention is necessary, regardless of the presence of symptoms.

Warnings and Precautions

Severe liver damage may occur in children who take more than five doses of this product containing acetaminophen within a 24-hour period, which is the maximum recommended daily amount. Additionally, the risk of liver damage increases if this product is used concurrently with other medications containing acetaminophen.

In cases of severe sore throat that persists for more than two days, or is accompanied by fever, headache, rash, nausea, or vomiting, it is imperative to consult a healthcare professional promptly.

This product should not be used in conjunction with any other drug containing acetaminophen, whether prescription or non-prescription. Healthcare professionals should advise patients to confirm the presence of acetaminophen in any other medications they may be taking.

Caution is advised when administering this product to children who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or have taken one within the past two weeks. MAOIs are commonly prescribed for depression, psychiatric conditions, or Parkinson's disease. If there is uncertainty regarding the presence of an MAOI in a prescription medication, consultation with a healthcare provider is recommended.

Before use, healthcare professionals should be consulted if the child has any of the following conditions: liver disease, heart disease, high blood pressure, thyroid disease, diabetes, or respiratory issues such as chronic bronchitis. Additionally, caution is warranted for children with a persistent or chronic cough, particularly if associated with smoking, asthma, chronic bronchitis, or emphysema, as well as for those experiencing a cough with excessive phlegm.

Patients taking the anticoagulant warfarin should seek advice from a healthcare professional before using this product.

In the event of an overdose, immediate medical assistance should be sought, or a poison control center should be contacted without delay. Prompt medical attention is crucial for both adults and children, even if no signs or symptoms are initially apparent.

Patients should discontinue use and consult a healthcare provider if they experience nervousness, dizziness, or sleeplessness. Additionally, if pain, nasal congestion, or cough worsens or persists beyond five days, or if fever worsens or lasts more than three days, medical advice should be sought. Redness or swelling, the emergence of new symptoms, or a recurrence of cough accompanied by a rash or persistent headache may indicate a serious condition and warrant immediate medical evaluation.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this product. Serious adverse reactions include the potential for severe liver damage, particularly in cases of overdose or when exceeding the maximum daily dosage of acetaminophen, which is five doses within a 24-hour period. Symptoms of liver damage may not be immediately apparent, thus it is crucial for patients to seek medical attention promptly in the event of an overdose.

Common adverse reactions that warrant immediate medical consultation include severe sore throat that persists for more than two days, especially if accompanied by fever, headache, rash, nausea, or vomiting. Additionally, patients should discontinue use and consult a healthcare provider if they experience nervousness, dizziness, or sleeplessness. Other concerning symptoms include worsening pain, nasal congestion, or cough lasting more than five days, fever that worsens or lasts more than three days, redness or swelling, the emergence of new symptoms, or a cough that recurs with a rash or persistent headache, as these may indicate a serious underlying condition.

In clinical practice, it is advised that patients with pre-existing conditions such as liver disease, heart disease, high blood pressure, thyroid disease, diabetes, or chronic respiratory issues (including chronic bronchitis or persistent cough) consult a healthcare professional prior to use. Furthermore, patients taking the anticoagulant warfarin should seek advice from a doctor or pharmacist before using this product, as interactions may occur.

In summary, while this product is effective for its intended use, careful attention to dosing and monitoring for adverse reactions is essential to ensure patient safety.

Drug Interactions

Concurrent use of this medication with any other drug containing acetaminophen, whether prescription or non-prescription, is contraindicated due to the risk of acetaminophen overdose and potential hepatotoxicity.

In pediatric patients, the use of this medication is contraindicated in those who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or have taken an MAOI within the past two weeks. MAOIs are commonly prescribed for depression, psychiatric, or emotional conditions, as well as for Parkinson's disease, and their interaction with this medication may lead to serious adverse effects.

Patients taking the anticoagulant warfarin should consult a healthcare professional, such as a doctor or pharmacist, prior to using this medication. Monitoring of coagulation parameters may be warranted to ensure safe use and to mitigate the risk of potential bleeding complications.

Packaging & NDC

Below are the non-prescription pack sizes of Childrens Tussnex (acteaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 6 to under 12 years may be administered 10 mL of the product using the dosing cup provided. The use of this product is not recommended for children under 6 years of age.

Healthcare professionals should be aware of the liver warning associated with this product, as it contains acetaminophen. Severe liver damage may occur if a child exceeds 5 doses within a 24-hour period, which is the maximum daily amount. Additionally, this product should not be used in children who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or within 2 weeks of discontinuing an MAOI.

Prior to administration, it is advisable to consult a physician if the pediatric patient has any of the following conditions: liver disease, heart disease, high blood pressure, thyroid disease, diabetes, or respiratory issues such as chronic bronchitis, persistent cough, or cough accompanied by excessive mucus.

Parents and caregivers should ensure that the product is kept out of reach of children. An overdose warning is in place, as taking more than the recommended dose may lead to liver damage. In the event of an overdose, immediate medical assistance should be sought, or a poison control center should be contacted, as prompt medical attention is crucial for both children and adults, even if no signs or symptoms are present.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Safety during pregnancy has not been established for this product. It is contraindicated in pregnant patients unless directed by a healthcare provider. The potential risks to the fetus are not specified; therefore, it is essential for women of childbearing potential to consult a healthcare provider for personalized advice.

No specific dosage modifications for pregnant individuals are provided; healthcare providers should be consulted for guidance on appropriate use. Pregnant individuals are advised to seek medical advice before using this product to ensure safety for both themselves and the developing fetus.

Lactation

Lactating mothers should consult a doctor before using this product. There is a potential for excretion in breast milk, and caution is advised when administering this product to nursing mothers due to the risk of infant exposure.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution and consider individual patient factors when prescribing to patients with reduced kidney function, as the absence of specific guidance necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment should consult a healthcare professional prior to use, particularly if there is a history of liver disease. It is important to note that exceeding the recommended dosage may lead to liver damage. In the event of an overdose, immediate medical assistance should be sought, and contacting a poison control center is advised. Prompt medical attention is crucial for both adults and children, even in the absence of noticeable signs or symptoms of overdose.

Overdosage

Taking more than the recommended dose of this medication may lead to liver damage. In the event of an overdose, it is imperative to seek medical assistance or contact a poison control center immediately. Prompt medical attention is crucial for both adults and children, even in the absence of noticeable signs or symptoms.

Healthcare professionals should be aware that the potential for liver damage underscores the importance of early intervention. Monitoring and supportive care may be necessary, depending on the severity of the overdose and the clinical presentation of the patient. It is essential to assess liver function and consider appropriate management strategies as part of the treatment protocol.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has identified several adverse reactions reported voluntarily or through surveillance programs. These include nervousness, dizziness, sleeplessness, pain, nasal congestion, and worsening of cough and fever. Additionally, reports of redness, swelling, new symptoms, returning cough, rash, and persistent headache have been noted. These reactions may indicate the presence of a serious condition.

Patient Counseling

Healthcare providers should advise patients not to use this product in conjunction with any other medication containing acetaminophen, whether prescription or non-prescription. If patients are uncertain about the presence of acetaminophen in their medications, they should be encouraged to consult a doctor or pharmacist.

It is important to inform patients that this product should not be administered to children who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or within two weeks of discontinuing such medication. Patients should be instructed to verify with a healthcare professional if they are unsure whether their prescription includes an MAOI.

Patients should be advised to seek medical advice before using this product if the child has any of the following conditions: liver disease, heart disease, high blood pressure, thyroid disease, diabetes, a breathing problem such as chronic bronchitis, a persistent or chronic cough associated with smoking, asthma, chronic bronchitis, or emphysema, or a cough that produces excessive phlegm.

Additionally, patients taking the blood-thinning medication warfarin should be counseled to consult a doctor or pharmacist prior to using this product.

When using this product, patients must be reminded to adhere strictly to the recommended dosage and not exceed it. They should be instructed to discontinue use and seek medical advice if they experience nervousness, dizziness, or sleeplessness; if pain, nasal congestion, or cough worsens or persists beyond five days; if fever worsens or lasts more than three days; if redness or swelling occurs; if new symptoms develop; or if a cough recurs or is accompanied by a rash or persistent headache, as these may indicate a serious condition.

Patients should be made aware of the overdose warning, emphasizing that taking more than the recommended dose can lead to liver damage. In the event of an overdose, they should seek medical assistance or contact a poison control center immediately, as prompt medical attention is crucial for both adults and children, even in the absence of noticeable signs or symptoms.

Finally, it is essential to remind patients to keep this product out of reach of children to prevent accidental ingestion.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available upon request. It is essential to store the product at a temperature range of 15-30°C (59-86°F). Refrigeration is not recommended, as it may compromise the integrity of the product. Proper handling should be observed to maintain the quality and efficacy of the product throughout its shelf life.

Additional Clinical Information

Patients should be advised that the medication is administered orally, with a maximum of 5 doses allowed within a 24-hour period. Doses may be repeated every 4 hours as needed while symptoms persist, but treatment should not exceed 5 days unless directed by a healthcare professional.

Clinicians should counsel patients to keep the medication out of reach of children and to be aware of the overdose warning. Taking more than the recommended dose can lead to liver damage, and in the event of an overdose, immediate medical assistance or contact with a poison control center is essential, regardless of the presence of symptoms.

Drug Information (PDF)

This file contains official product information for Childrens Tussnex, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)